A randomized study comparing interferon (IFNα) plus low-dose cytarabine and interferon plus hydroxyurea (HU) in early chronic-phase chronic myeloid leukemia (CML)

Autor: Kühr, T., Burgstaller, S., Apfelbeck, U., Linkesch, W., Seewann, H., Fridrik, M., Michlmayr, G., Krieger, O., Lutz, D., Lin, W., Pont, J., Köck, L., Abbrederis, K., Baldinger, C., Buder, R., Geissler, D., Hausmaninger, H., Lang, A., Zabernigg, A., Duba, C., Hilbe, W., Eisterer, W., Fiegl, M., Greil, R., Gastl, G., Thaler, J.
Zdroj: In Leukemia Research 2003 27(5):405-411
Databáze: ScienceDirect